JP2023520405A5 - - Google Patents
Info
- Publication number
- JP2023520405A5 JP2023520405A5 JP2022559594A JP2022559594A JP2023520405A5 JP 2023520405 A5 JP2023520405 A5 JP 2023520405A5 JP 2022559594 A JP2022559594 A JP 2022559594A JP 2022559594 A JP2022559594 A JP 2022559594A JP 2023520405 A5 JP2023520405 A5 JP 2023520405A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- compound
- guanine
- cytosine
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025272734A JP2026048940A (ja) | 2020-03-30 | 2025-12-22 | 改変ペプチド核酸組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063002326P | 2020-03-30 | 2020-03-30 | |
| US63/002,326 | 2020-03-30 | ||
| PCT/US2021/025019 WO2021202621A2 (en) | 2020-03-30 | 2021-03-30 | Modified peptide nucleic acid compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025272734A Division JP2026048940A (ja) | 2020-03-30 | 2025-12-22 | 改変ペプチド核酸組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023520405A JP2023520405A (ja) | 2023-05-17 |
| JP2023520405A5 true JP2023520405A5 (cg-RX-API-DMAC7.html) | 2024-08-20 |
| JP7796038B2 JP7796038B2 (ja) | 2026-01-08 |
Family
ID=77921451
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022559594A Active JP7796038B2 (ja) | 2020-03-30 | 2021-03-30 | 改変ペプチド核酸組成物 |
| JP2025272734A Pending JP2026048940A (ja) | 2020-03-30 | 2025-12-22 | 改変ペプチド核酸組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025272734A Pending JP2026048940A (ja) | 2020-03-30 | 2025-12-22 | 改変ペプチド核酸組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (6) | US20210309997A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4127228A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7796038B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021246046A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3173015A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021202621A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7796038B2 (ja) * | 2020-03-30 | 2026-01-08 | ニューベース セラピューティクス, インコーポレイテッド | 改変ペプチド核酸組成物 |
| CA3173504A1 (en) * | 2020-12-15 | 2022-06-23 | Dietrich A. Stephan | Oligonucleotide analogue therapeutics for treatment of neuromuscular disease |
| WO2023244536A2 (en) * | 2022-06-13 | 2023-12-21 | Neubase Therapeutics, Inc. | Oligonucleotide analogue formulations |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080038783A1 (en) * | 2006-06-29 | 2008-02-14 | Applera Corporation | Compositions and Methods Pertaining to Guanylation of PNA Oligomers |
| JP6047270B2 (ja) | 2006-08-11 | 2016-12-21 | バイオマリン テクノロジーズ ベー.フェー. | Dnaリピートの不安定性に関連した遺伝的障害を治療するための方法及び手段 |
| WO2008061091A2 (en) | 2006-11-13 | 2008-05-22 | Grandis Jennifer R | Antisense guanidinium peptide nucleic acid (gpna) oligonucleotides as antitumor agents |
| AU2009276763B2 (en) * | 2008-07-29 | 2015-07-16 | The Board Of Regents Of The University Of Texas Sytem | Selective inhibition of polyglutamine protein expression |
| WO2015172058A1 (en) | 2014-05-08 | 2015-11-12 | Carnegie Mellon University | Left-handed gamma-peptide nucleic acids, methods of synthesis and uses therefor |
| CN111757935B (zh) * | 2017-12-21 | 2025-02-21 | 卡耐基梅隆大学 | 二价核酸配体及其用途 |
| WO2020172664A1 (en) * | 2019-02-22 | 2020-08-27 | Carnegie Mellon University | Tuning binding cooperativity in nucleic acid targeting compounds |
| JP7796038B2 (ja) | 2020-03-30 | 2026-01-08 | ニューベース セラピューティクス, インコーポレイテッド | 改変ペプチド核酸組成物 |
-
2021
- 2021-03-30 JP JP2022559594A patent/JP7796038B2/ja active Active
- 2021-03-30 WO PCT/US2021/025019 patent/WO2021202621A2/en not_active Ceased
- 2021-03-30 US US17/218,145 patent/US20210309997A1/en not_active Abandoned
- 2021-03-30 CA CA3173015A patent/CA3173015A1/en active Pending
- 2021-03-30 EP EP21781683.4A patent/EP4127228A4/en active Pending
- 2021-03-30 AU AU2021246046A patent/AU2021246046A1/en active Pending
- 2021-04-15 US US17/231,997 patent/US20210324012A1/en not_active Abandoned
- 2021-04-15 US US17/232,000 patent/US20220112238A1/en not_active Abandoned
- 2021-04-15 US US17/231,998 patent/US20210309700A1/en not_active Abandoned
- 2021-04-15 US US17/232,001 patent/US11603530B2/en active Active
-
2023
- 2023-01-27 US US18/102,415 patent/US20230174985A1/en not_active Abandoned
-
2025
- 2025-12-22 JP JP2025272734A patent/JP2026048940A/ja active Pending